...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: BETonMACE Enrollment

"And the fact that the published report a few weeks back stated "2700 patient years on Apabetalone", which backs out to 2400 on Phase 3 dosed patient years...implying 4800+ patient years for the trial, muddies the picture ever so much."

What published report providing BETonMACE patient year data? I have not seen any published reports on BETonMACE patient years. Please provide your source here. 

BearDownAZ 

Share
New Message
Please login to post a reply